Drug Profile
Research programme: immuno-oncolytic cancer therapeutics - Western Oncolytics
Alternative Names: WO 12; WO-VET-S3Latest Information Update: 28 May 2021
Price :
$50
*
At a glance
- Originator Western Oncolytics
- Class Gene therapies; Oncolytic viruses
- Mechanism of Action Gene transference; Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer